Company: BIVIW
Filing Date: 2025-10-06
Form Type: POS AM
Source: 0001520138-25-000294
Chunk: 33

Company: BIOVIE INC.
Filing Date: 2025-10-06
Form: POS AM
Chunk 33
---
 the contrary) made with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the
Exchange Act, including those made after the date of the initial filing of the registration statement of which this prospectus is a part
and prior to effectiveness of such registration statement, until we file a post-effective amendment that indicates the termination of
this offering and will become a part of this prospectus from the date that such documents are filed with the SEC. Information in such
future filings updates and supplements the information provided in this prospectus. Any statements in any such future filings will automatically
be deemed to modify and supersede any information in any document we previously filed with the SEC that is incorporated or deemed to be
incorporated herein by reference to the extent that statements in the later filed document modify or replace such earlier statements.

| 21 |

We will furnish without charge to each person, including
any beneficial owner, to whom a prospectus is delivered, upon written or oral request, a copy of any or all of the documents incorporated
by reference into this prospectus but not delivered with this prospectus, including exhibits that are specifically incorporated by reference
into such documents. You should direct any requests for documents to BioVie Inc., Attention: Corporate Secretary, 680 W Nye Lane, Suite
201, Carson City, Nevada 89703. Our phone number is (775) 888-3162.

You may also access these documents, free of charge
on the SEC’s website at www.sec.gov or on our website at https://bioviepharma.com. Information contained on our website is
not incorporated by reference into this prospectus, and you should not consider any information on, or that can be accessed from, our
website as part of this prospectus or any accompanying prospectus supplement.

You should rely only on information contained in,
or incorporated by reference into, this prospectus and any prospectus supplement. We have not authorized anyone to provide you with information
different from that contained in this prospectus or incorporated by reference into this prospectus. We are not making offers to sell the
securities in any jurisdiction in which such an offer or solicitation is not authorized or in which the person making such offer or solicitation
is not qualified to do so or to anyone to whom it is unlawful to make such offer or solicitation.

| 22 |

<div align='center'>Up to 380,000 Shares of Class A Common Stock Underlying